Recruiting Patients.
Advancing Research.

A New Research Study for People With Severe Emphysema

The IAB-2 study is a clinical research study designed to gather new information about the safety and effectiveness of implanted Implantable Artificial Bronchus (IAB) devices in people with severe emphysema.

Who May Qualify?

To participate in the IAB-2 study, individuals must meet certain eligibility requirements, including:

  • We conduct rigorous evaluations that illuminate inefficiencies and establish a definitive baseline for improvement.

  • We refine end-to-end workflows, eliminating redundancies and embedding continuous improvement protocols.

  • We cultivate expertise through structured training and mentorship that empower teams to drive sustained progress.

Who May Qualify?

To participate in the IAB-2 study, individuals must meet certain eligibility requirements, including:

Have severe emphysema

Be 22 years of age or older

Have a body mass index (BMI) between 18 and 35

Have been smoke-free for at least four months

Have had no hospitalization for a COPD exacerbation (flare-up) within the past six weeks, and no more than two such hospitalizations in the past year

Innovation in the Treatment of COPD/Emphysema

LEARN MORE